Sonova Didn’t Lose on Sennheiser. It Got Exactly What It Paid For

Sonova's announcement that it is putting Sennheiser's consumer division back on the market just four years after acquiring it for €200 million has predictably set off alarm bells in audiophile circles.

The narrative writes itself: hearing aid company buys iconic headphone brand, doesn't know what to do with it, and flips it. But in my opinion, that probably misses the point entirely.

Consider what Sonova actually bought. Sennheiser is one of the most respected names in headphones and consumer audio. It has spent decades perfecting transducer design, acoustic tuning, and the science of how music should sound in and around the human ear. Much of that expertise doesn't exist in hearing aid laboratories. It exists in companies that make headphones for a living.

Based on some basic stats I found, the global hearing aid market is estimated to grow from roughly USD 10 billion in 2025 to around USD 20 billion by 2035. An ageing population is driving demand, and the rise of over-the-counter hearing devices in many countries is expanding the market beyond traditional clinical channels. But there is a well-documented weakness in hearing aids that the audiology industry often fails to admit: they sound terrible for music.

Of course, hearing aids are optimised for speech, not music. Their microphones saturate at the higher sound pressure levels that music demands. Wide dynamic range compression distorts spectral balance. Noise reduction and feedback suppression interfere with the temporal and tonal qualities that make music sound like music. Users consistently report dissatisfaction, and according to an American Academy of Audiology study this year, almost 60% say music was never even discussed during their fitting.

This is the gap Sonova needed to close, and one I championed as the reason that Sonova would have bought Sennheiser in the first instance. Not by selling more headphones, but through understanding how to make hearing devices that can handle music properly. And who better to learn from the company whose entire identity is built on audio fidelity?

For four years, one would assume that Sonova had full access to Sennheiser's R&D, acoustic engineering, transducer technology, and consumer product design philosophy. It had a prime view of how a premium consumer audio company approaches retail distribution, brand positioning, and direct-to-consumer marketing.

The numbers tell you how small this bet really was. In the 2024/25 financial year, Sonova's Consumer Hearing business, which is the entire Sennheiser operation, generated CHF 252.5 million in revenue. The rest of the group brought in CHF 3.6 billion. So, Sennheiser accounted for just 6.5% of Sonova's total sales. This was never a pillar of the business. It was a tactical acquisition at a manageable price.

And here's the thing: Sonova will sell it. The Sennheiser consumer brand retains significant value, and the premium headphone market is consolidating around well-capitalised platform players. Whoever buys it will pay a fair price for the brand, the product portfolio, and the Wedemark, Germany operation. I dare say Sonova may well recover most, if not all, of its original €200 million outlay.

If that happens, the effective cost of four years of embedded access to one of the world's foremost audio engineering operations, from its people to its patents, and its institutional knowledge of how to make things sound right, was close to zero.

That is not a failed acquisition. That is an extraordinarily efficient piece of corporate strategy.

The real question is not why Sonova is selling. It is whether the hearing aids that come out of Stäfa over the next five years sound noticeably better for music than anything the industry has produced before. If they do, we will know exactly where that capability came from.

Join the discussion